Prognosis for Poorly Differentiated, High-Grade Rectal Neuroendocrine Carcinomas.

Patients with rNECs experience dismal survival outcomes, including those with non-metastatic disease treated with curative-intent surgical resection. Neoadjuvant therapy can serve as a useful biologic test, and surgical resection should be judiciously employed.